Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
Vir Biotechnology has exclusive rights to the universal PRO-XTEN® masking platform for oncology and infectious disease. PRO-XTEN® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.
The Director, Competitive Intelligence & Insights - Oncology will execute competitive intelligence activities across several of Vir Bio’s early-stage clinical programs and Research projects across solid tumor indications.
The role directly supports Clinical Development, Medical Affairs, Commercial, Program Management, Corporate Strategy and Business Development functions, and will require significant cross-functional collaboration and interaction with senior leadership across the organization.
The primary responsibilities include collecting and synthesizing relevant insights from external sources (leveraging modern tools including agentic AI) and presenting implications to support decision making across the organization. These activities will be driven by the need for: a) a broad understanding of the solid tumor therapeutic landscape, and b) answering key strategic questions to be defined by relevant stakeholders.
This role is based in our San Francisco California office with the expectations to be onsite 4 days a week.
WHAT YOU'LL DO- Maintain and update competitive landscape analyses and competitor profiles for Vir Bio therapeutic areas of focus and deliver accurate, timely, and actionable updates to key stakeholders
- Communicate context, insights and objective analysis of competitive information to Program Teams and Senior Leadership throughout the organization to support clinical and program decision making, as well as corporate communications and investor relations
- Cover major conferences, including synthesis of key abstracts, publications and presentations to provide insights on emerging scientific and clinical data
- Collaborate with partners in Clinical Development, Medical Affairs, Commercial, Program Management, Corporate Strategy and Business Development functions to define key strategic questions and support competitive intelligence needs
- Advanced degree in a scientific or engineering field and 8+ years of Competitive Intelligence, Strategy Consulting or Buy Side experience in biotech/pharma
- Demonstrated excellence in scientific evaluation
- Education and relevant work experience in solid tumor oncology, including expertise across biologics modalities
- Excellent organization, planning and time management skills including the ability to support and prioritize multiple projects
- Demonstrated communication, presentation and interpersonal skills required to present complex data to senior stakeholders
- Collaborative and flexible in personal interactions at all levels of the company
- Demonstrated business experience and acumen
- Experience with LLM-guided analyses, including oversight of agentic AI-initiated analyses
- Experience in use of online data sources and scientific/market databases (e.g., ClinicalTrials.gov, Cortellis, etc.)
The expected salary range for this position is $195,000 to $272,000 per year. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.
Vir Biotechnology's compensation and benefits are aligned with the current market and commensurate with the person’s experience and qualifications. All full-time employees receive a package that includes compensation, bonus and equity as well as many other Vir Biotechnology benefits and perks such as health and welfare benefit plans, non-accrual paid time off, company shut down for holidays, commuter benefits, 401K match and lunch each day in the office.
Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to any legally protected characteristics.
This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs. Vir Biotechnology also strongly commits to providing employees with a work environment free of unlawful conduct or harassment.
Vir Biotechnology Human Resources leads recruitment and employment for Vir Biotechnology. Unsolicited resumes sent to the company from recruiters do not constitute any type of relationship between the recruiter and Vir Biotechnology and do not obligate us to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees.
For hires based in the United States, Vir Biotechnology, participates in E-Verify.
Candidate Privacy Notice
Vir Biotechnology San Francisco, California, USA Office
San Francisco, CA, United States
Similar Jobs
.png)
What you need to know about the San Francisco Tech Scene
Key Facts About San Francisco Tech
- Number of Tech Workers: 365,500; 13.9% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Google, Apple, Salesforce, Meta
- Key Industries: Artificial intelligence, cloud computing, fintech, consumer technology, software
- Funding Landscape: $50.5 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Sequoia Capital, Andreessen Horowitz, Bessemer Venture Partners, Greylock Partners, Khosla Ventures, Kleiner Perkins
- Research Centers and Universities: Stanford University; University of California, Berkeley; University of San Francisco; Santa Clara University; Ames Research Center; Center for AI Safety; California Institute for Regenerative Medicine
